UK markets close in 8 hours 19 minutes

AXIM Biotechnologies, Inc. (AXIM)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0140-0.0008 (-5.41%)
At close: 03:38PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-5,589
-8,060
-6,243
-16,032
-6,410
-
Depreciation & amortisation
428.271
427.019
426.126
2,116
16.001
-
Stock-based compensation
103.518
197.727
1,107
1,144
2,312
-
Change in working capital
-160.031
1,292
1,039
-28.182
485.77
-
Accounts receivable
-
-
-
-
-
-315.843
Inventory
-
-
20.089
-20.089
-
-478.017
Accounts payable
-520.201
769.03
659.4
277.507
532.245
-
Other working capital
-1,958
-1,030
-2,053
-2,537
-3,313
-
Other non-cash items
2,493
2,043
2,125
2,769
458.728
-
Net cash provided by operating activities
-1,956
-1,030
-2,044
-2,487
-3,216
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-8.71
-50.495
-97.324
-
Acquisitions, net
-
-
-
-
-
-27.49
Sales/maturities of investments
-
-
-
-
0
375.677
Net cash used for investing activities
-2.839
0
-8.71
-50.495
9.98
-
Cash flows from financing activities
Debt repayment
-
0
-1,333
-120
0
-
Common stock issued
1,227
491.456
1,742
1,636
3,309
-
Other financing activities
-
-26.781
-86.706
7.504
-92.86
-
Net cash used provided by (used for) financing activities
2,002
1,140
1,647
2,533
3,216
-
Net change in cash
43.169
109.175
-405.681
-4.218
-54.449
-
Cash at beginning of period
53.542
47.282
452.963
457.181
511.63
-
Cash at end of period
96.711
156.457
47.282
452.963
457.181
-
Free cash flow
Operating cash flow
-1,956
-1,030
-2,044
-2,487
-3,216
-
Capital expenditure
-
-
-8.71
-50.495
-97.324
-
Free cash flow
-1,958
-1,030
-2,053
-2,537
-3,313
-